½ÃÀ庸°í¼­
»óǰÄÚµå
1446488

µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå - ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç° À¯Çüº°, ±â¼úº°, µ¿¹° À¯Çüº°, °Ë»ç Ä«Å×°í¸®º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

Veterinary Rapid Test Market Size, Share & Trends Analysis Report By Product (Test Kits, Readers), By Technology (Immunoassays, PCR), By Animal Type, By Testing Category, By End-use, By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 180 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀåÀÇ ¼ºÀå ¹× µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 18¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2024³âºÎÅÍ 2030³â±îÁöÀÇ CAGRÀº 12.33%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ ½ÃÀåÀº ÁÖ·Î µ¿¹° Àα¸ ¹× »çÀ°·ü Áõ°¡, µ¿¹° ÁöÃâ Áõ°¡, µ¿¹° ¿¹¹æ °Ç°­ °ü¸®¿¡ ÁßÁ¡À» µÎ°í, µ¿¹° ½Å¼Ó °Ë»ç ŰƮÀÇ Áøº¸, ¹Ý·Áµ¿¹° º¸Çè ä¿ë·ü »ó½ÂÀ¸·Î ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ¿µ±¹À» Æ÷ÇÔÇÏ¿© ¹Ý·Áµ¿¹°Àº ¸ðµç °¡Á¤¿¡¼­ Á¤»óÀûÀ¸·Î ±æµéÀÔ´Ï´Ù. 2024³â Pet KeenÀÌ ¹ßÇ¥ÇÑ ±â»ç¿¡ µû¸£¸é 2021³â ¿µ±¹ ¹Ý·Áµ¿¹° Àα¸´Â °³ 1,250¸¸ ¸¶¸®, °í¾çÀÌ 1,220¸¸ ¸¶¸®·Î ÃßÁ¤µË´Ï´Ù. ¹Ý·Áµ¿¹°À» Ű¿ì´Â °¡Á¤ÀÌ ´Ã¾î³²¿¡ µû¶ó È¿À²ÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î °Ç°­ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹Ý·Áµ¿¹° »çÀ°ÀÇ ±ÞÁõÀº µ¿¹° º´¿ø¿¡¼­ ½Å¼Ó °Ë»ç ŰƮÀÇ Çʿ伺À» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¹Ý·Áµ¿¹°ÀÇ °Ç°­ ¹× º¹Áö¸¦ º¸ÀåÇϱâ À§ÇØ ÁÖÀÎÀº Á¡Á¡ ´õ Æí¸®Çϰí Àû½Ã¿¡ °Ë»ç µµ±¸¸¦ ã°í ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ °Ë»ç ŰƮ ½ÃÀåÀº ±¹³» ¹Ý·Áµ¿¹°µé »çÀÌ¿¡¼­ ¿ä·Î °¨¿°(UTI)ÀÇ ³ôÀº À¯º´·ü ¶§¹®¿¡ ¾ÈÁ¤ÀûÀÌ°í ±àÁ¤ÀûÀÎ Àü¸ÁÀ» ¿¹»óÇÒ °ÍÀÔ´Ï´Ù. ¹Ý·Áµ¿¹°ÀÇ Áúº´¿¡¼­ °¡Àå ÈçÇÑ Áø´Ü Áß Çϳª´Â ¼¼±Õ¼º ¿ä·Î °á¼®ÁõÀ̸ç Ç×»ýÁ¦ ó¹æÀÇ ÁÖ¿ä ¿øÀÎÀÔ´Ï´Ù. 2022³â¿¡ Antibiotics Journal¿¡ °ÔÀçµÈ µ¶ÀÏÀÇ °³¿Í °í¾çÀ̷κÎÅÍÀÇ ¿ä·Î º´¿øÃ¼ÀÇ À¯º´·ü¿¡ °üÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é, °í¾çÀÌ ½Ã·áÀÇ 38.5%, °³ ½Ã·áÀÇ 43.9%¿¡¼­ ¿ä·Î º´¿øÃ¼ÀÇ Áõ½ÄÀÌ ÀÎÁ¤µÇ¾ú½À´Ï´Ù. °Ô´Ù°¡ ȸ¼öµÈ º´¿øÃ¼¿¡¼­ °¡Àå ¸¹¾Ò´ø °ÍÀº ´ëÀå±Õ(48.4%)À¸·Î, ÄھƱ׶ó¾ÆÁ¦ ¾ç¼º Æ÷µµ»ó±¸±Õ(CoPS; 11.5%), À屸±Õ¼Ó(11.9%)ÀÌ À̾îÁ³½À´Ï´Ù.

¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ Á¦Ç° Ãâ½Ã È®´ë´Â µ¿¹°¿ë ½Å¼Ó °Ë»ç ŰƮ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÅÁ¦Ç°Àº µ¿¹° ÀÇÇÐÀÇ »õ·Î¿î ¿ä±¸¸¦ ÃæÁ·½Ãŵ´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 10¿ù Zoetis´Â Basepaws Breed Health Dog DNA Test¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ Çõ½ÅÀûÀÎ °Ë»ç´Â °£´ÜÇÑ ½º¿Íºù ÇÁ·Î¼¼½º ¹× ¸ð¹ÙÀÏ ÀåÄ¡¿¡ ¸Â°Ô Á¶Á¤µÈ °á°ú ´öºÐ¿¡ ¹Ý·Áµ¿¹° ¼ÒÀ¯ÀÚ°¡ ¹Ý·Áµ¿¹° °ü¸®Áß ¹ÝÀÀÀû Á¢±Ù¿¡¼­ Àû±ØÀûÀÎ Á¢±ÙÀ¸·Î ÀüȯÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ÀÌ Á¦Ç°Àº Á¢±ÙÇϱ⠽±°í »ç¿ëÇϱ⠽¬¿î À¯ÀüÀÚ °Ë»ç¸¦ ÅëÇØ ÁÖÀÎÀÌ ¾Ö°ßÀÇ °Ç°­¿¡ Àû±ØÀûÀÎ ¿ªÇÒÀ» ÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â µ¥ Å« µµ¾àÀ» ÀǹÌÇÕ´Ï´Ù.

µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • Á¦Ç°º°·Î´Â °Ë»ç ŰƮ ºÐ¾ß°¡ 2023³â 80%ÀÇ ÃÖ´ë ¼öÀÍ Á¡À¯À²·Î ½ÃÀåÀ» ¼±µµÇÏ¿´°í ¼öÀÇ»ç Áø´Ü °Ë»ç¿¡ À־ÀÇ ±â¼ú Áøº¸ Áõ°¡¿¡ ÀÇÇØ ¿¹Ãø ±â°£ Áß¿¡ 12.53%ÀÇ °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
  • µ¿¹° À¯Çüº°·Î ¹Ý·Áµ¿¹° ¼¼ºÐÈ­´Â 2023³â¿¡ °¡Àå Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇÏ¿´À¸¸ç, ¹Ý·Áµ¿¹° Àα¸ÀÇ ±ÞÁõ ¹× ³ôÀº ¹Ý·Áµ¿¹° ÁöÃâ·Î ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
  • ±â¼úº°·Î, ¸é¿ªºÐ¼® ºÐ¾ß´Â 2023³â ÃÖ´ëÀÇ ¼öÀÍ Á¡À¯À²·Î ½ÃÀåÀ» ¼±µµÇß½À´Ï´Ù. PCR ±â¼ú ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Immunoassay ±â¹ÝÀÇ ºü¸¥ °Ë»ç ŰƮ´Â ¹Ý·Áµ¿¹°(¿¹ : °³ ÆÄº¸¹ÙÀÌ·¯½º ¹× °í¾çÀÌ ¹éÇ÷º´ ¹ÙÀÌ·¯½º) ¹× °¡Ãà(¿¹ : ¼Ò ¹ÙÀÌ·¯½º¼º ¼³»ç ¹ÙÀÌ·¯½º ¹× Á¶·ù ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º)ÀÇ °¨¿°°ú °°Àº ´Ù¾çÇÑ ¼öÀÇÇÐ º´¿øÃ¼ ¹× º´ÅÂÀÇ °ËÃâ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • °Ë»ç Ä«Å×°í¸®º°·Î ¹ÙÀÌ·¯½ºÇÐ ºÐ¾ß´Â 2023³â¿¡ °¡Àå Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ´Â µ¿¹°°£ ¹ÙÀÌ·¯½º¼º ÁúȯÀÇ ¸¸¿¬À» ¾ïÁ¦Çϱâ À§ÇØ ¿¹¹æÀÇ·á ÇÁ·Î±×·¥À» ½Ç½ÃÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºêÀÌ È®´ëµÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ÇÑÆí, ±â»ýÃæ ºÎ¹®Àº ¹Ý·Áµ¿¹° ¹× »ý»ê µ¿¹°¿¡¼­ ±â»ýÃæ °¨¿°ÀÇ À¯º´·üÀÌ Áõ°¡ÇÏ°í ´Ù¾çÇÑ °Ë»ç ŰƮÀÇ °¡¿ë¼ºÀ¸·Î ÀÎÇØ ÃßÁ¤ ¹× ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµº°·Î´Â µ¿¹°º´¿ø ¹× Ŭ¸®´Ð ºÐ¾ß°¡ 2023³â¿¡ ÃÖ´ëÀÇ ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇØ ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ÀçÅà ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
  • ºÏ¹Ì´Â 2023³â ¸ÅÃâ Á¡À¯À² 36%·Î ½ÃÀåÀ» µ¶Á¡ÇÏ¿´½À´Ï´Ù. ¹Ý¸é ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È 14.40%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ±Þ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
  • ½Å¼Ó °Ë»ç ±â¼úÀÇ ¹ßÀüÀ¸·Î º¸´Ù Á¤È®ÇÏ°í »ç¿ëÇϱ⠽±°í ºñ¿ë È¿À²ÀûÀÎ µ¿¹°¿ë ½Å¼Ó °Ë»ç ŰƮ°¡ °³¹ßµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Áøº¸°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý ¹× ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå µ¿¹°¿ë ½Å¼Ó °Ë»ç ŰƮ ½ÃÀåÀÇ ¾÷°è Àü¸Á

  • ½ÃÀå °èÅë Àü¸Á
  • µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå ¿ªÇÐ
  • µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå : Porter's Five Forces ºÐ¼®
  • µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå : PESTEL ºÐ¼®
  • °¡°Ý ºÐ¼®
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
  • ±â¼ú Æ®·»µå ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦4Àå Á¦Ç°º° ÃßÁ¤ ¹× µ¿Ç⠺м®(2018-2030³â)(100¸¸ ´Þ·¯)

  • Á¦Ç°º° µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
  • Á¦Ç°º° º¯µ¿ ºÐ¼® ¹× ½ÃÀå Á¡À¯À²(2023³â, 2030³â)
  • Á¦Ç°º°
  • °Ë»ç ŰƮ
    • °Ë»ç ŰƮ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)

Á¦5Àå °Ë»ç Ä«Å×°í¸®º° ÃßÁ¤ ¹× µ¿Ç⠺м®(2018-2030³â)(100¸¸ ´Þ·¯)

  • °Ë»ç Ä«Å×°í¸®º° µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
  • °Ë»ç Ä«Å×°í¸®º° º¯µ¿ ºÐ¼® ¹× ½ÃÀå Á¡À¯À²(2023³â, 2030³â)
  • °Ë»ç Ä«Å×°í¸®º°
  • ¹ÙÀÌ·¯½ºÇÐ
    • ¹ÙÀÌ·¯½ºÇÐ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
  • ±â»ýÃæÇÐ
    • ±â»ýÃæÇÐ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
  • ¼¼±ÕÇÐ
    • ¼¼±ÕÇÐ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
  • ÀÓ»ó È­ÇÐ
    • ÀÓ»ó È­ÇÐ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
  • ±âŸ
    • ±âŸ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)

Á¦6Àå ±â¼úº° ÃßÁ¤ ¹× µ¿Ç⠺м®(2018-2030³â)(100¸¸ ´Þ·¯)

  • ±â¼úº° µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
  • ±â¼úº° º¯µ¿ ºÐ¼® ¹× ½ÃÀå Á¡À¯À²(2023³â, 2030³â)
  • ±â¼úº°
  • ¸é¿ªÇÐÀû °Ë»ç
    • ¸é¿ª °ËÁ¤ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
  • PCR
    • PCR ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)

Á¦7Àå µ¿¹° À¯Çüº° ÃßÁ¤ ¹× µ¿Ç⠺м®(2018-2030³â)(100¸¸ ´Þ·¯)

  • µ¿¹° À¯Çüº° µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
  • µ¿¹° À¯Çüº° ºÐ¼® ¹× ½ÃÀå Á¡À¯À²(2023³â, 2030³â)
  • µ¿¹° À¯Çüº°
    • ¹Ý·Á µ¿¹°º°
    • »ý»ê µ¿¹°º°
  • ¹Ý·Á µ¿¹°
    • ¹Ý·Áµ¿¹° ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
    • °³
    • °í¾çÀÌ
    • ¸»
    • ±âŸ
  • »ý»ê µ¿¹°
    • »ý»ê µ¿¹° ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
    • ¼Ò
    • °¡±Ý
    • µÅÁö
    • ±âŸ

Á¦8Àå ÃÖÁ¾ ¿ëµµº° ÃßÁ¤ ¹× µ¿Ç⠺м®(2018-2030³â)(100¸¸ ´Þ·¯)

  • ÃÖÁ¾ ¿ëµµº° µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
  • ÃÖÁ¾ ¿ëµµº° ºÐ¼® ¹× ½ÃÀå Á¡À¯À²(2023³â, 2030³â)
  • ÃÖÁ¾ ¿ëµµº°
  • µ¿¹°º´¿ø ¹× Ŭ¸®´Ð
    • µ¿¹° º´¿ø ¹× Ŭ¸®´Ð ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
  • ÀçÅà ġ·á ȯ°æ
    • ÀçÅà ġ·á ȯ°æ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
  • ±âŸ
    • ±âŸ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)

Á¦9Àå Áö¿ªº° ÃßÁ¤ ¹× µ¿Ç⠺м®(2018-2030³â)(100¸¸ ´Þ·¯)

  • Áö¿ªº° Àü¸Á
  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â, 2030³â)
  • Áö¿ªº° ¸¶ÄÏÇ÷¹À̽º, Áß¿äÇÑ Æ÷ÀÎÆ®
  • ºÏ¹Ì
    • ºÏ¹ÌÀÇ µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ÀÇ µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ½º¿þµ§
    • µ§¸¶Å©
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« µ¿¹°¿ë ½Å¼Ó °Ë»ç ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018-2030³â)
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Äí¿þÀÌÆ®

Á¦10Àå °æÀï ±¸µµ

  • ½ÃÀå ÁøÃâ±â¾÷ÀÇ ºÐ·ù
  • Participants Overview
  • À繫 ½ÇÀû
  • Á¦Ç° º¥Ä¡¸¶Å·
  • ½ÃÀå Æ÷Áö¼Å´× ºÐ¼®(2023)(È÷Æ® ¸Ê ºÐ¼®)
  • Àü·« ¸ÅÇÎ
    • ÇÕº´ ¹× Àμö
    • ¹ß¸Å
    • ÆÄÆ®³Ê½Ê ¹× Çù¾÷
    • È®´ë
    • ±âŸ
  • ´Ù¸¥ ÁÖ¿ä ½ÃÀå ±â¾÷ ¸ñ·Ï
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Zoetis.
    • IDEXX Laboratories, Inc.
    • Virbac.
    • Heska Corporation(Mars Inc.)
    • Thermo Fisher Scientific, Inc.
    • Neogen Corporation.
    • Prometheus Bio Inc.
    • Fassisi GmbH.
    • Biopanda Reagents Ltd.
    • Boster Biological Technology.

Á¦11Àå Áß¿äÇÑ Æ÷ÀÎÆ®

AJY 24.03.21

Veterinary Rapid Test Market Growth & Trends:

The global veterinary rapid test market size is anticipated to reach USD 1.85 billion by 2030, and it is projected to grow at a CAGR of 12.33% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by the increasing animal population and ownership rates, elevated spending on animals, a heightened emphasis on preventive healthcare for animals, advancements in veterinary rapid test kits, and rising adoption of pet insurance. Pets are commonly found in homes everywhere, including in the UK. According to the article published by Pet Keen in 2024 stated that the pet population in the UK in 2021 was estimated to be 12.5 million dogs & 12.2 million cats. As more households adopt companions into their homes, there's an increased demand for efficient and accessible healthcare solutions. This surge in pet ownership drives the need for rapid test kits in veterinary practices, as pet owners increasingly seek convenient and timely diagnostic tools to ensure the health and

well-being of their pets.

The market for these diagnostic kits will see a steady positive outlook due to the high prevalence of Urinary Tract Infections (UTIs) among companion animals in the country. One of the most common diagnoses in companion animal illnesses is bacterial UTI, which is the main cause of antibiotic prescriptions. According to data on the prevalence of uropathogens in cats and dogs from Germany published in the Antibiotics Journal in 2022, uropathogenic growth was found in 38.5% of cat samples and 43.9% of dog samples. Furthermore, Escherichia coli (48.4%) was the most common pathogen recovered, followed by Coagulase-positive Staphylococci (CoPS; 11.5%) and Enterococcus spp. (11.9%).

In addition, the expansion of product launches by key players is propelling growth in the veterinary rapid test kit market. These new products address emerging needs in veterinary medicine. For instance, in October 2023, Zoetis launched the Basepaws Breed + Health Dog DNA Test.This innovative test enables pet owners to shift from a reactive to a proactive approach in pet care, thanks to its simple swabbing process and results tailored for mobile devices. This product marks a significant leap forward in empowering pet owners to take a more proactive role in their dogs' health through accessible and user-friendly genetic testing.

Veterinary Rapid Test Market Report Highlights:

  • Based on product, the test kits segment led the market with a largest revenue share of 80% in 2023 and is expected to grow at the fastest CAGR of 12.53% during forecast period due to an increase in technological advancements in veterinary diagnostic tests
  • Based on animal type, the companion animals segment held the market with largest revenue share in 2023 and is projected to grow at fastest CAGR during the forecast period, owing to a surge in pet population and high pet spending
  • In terms of technology, the immunoassays segment led the market with largest revenue share in 2023. The PCR technology segment is projected to grow at the fastest CAGR during forecast period. The Immunoassay-based rapid test kits are available for the detection of various veterinary pathogens and conditions, such as infectious diseases in companion animals (e.g., canine parvovirus & feline leukaemia virus) and livestock (e.g., bovine viral diarrhea virus & avian influenza virus)
  • Based on testing category, the virology segment held the market with the largest revenue share in 2023, due to growing government's initiatives to implement preventive healthcare programs to reduce the spread of viral diseases among animals. On other hand, the parasitology segment is estimated to grow at fastest CAGR during forecast period, due to increasing prevalence of parasitic infections in companion & production animals and the availability of various test kits
  • Based on end-use, the veterinary hospitals & clinics segment held the market with the largest revenue share in 2023, owing to the increasing demand for diagnostics and readily accessible advanced diagnostic technologies in hospitals. The home setting segment is estimated to grow at fastest CAGR in the forecast period
  • North America dominated the market with the revenue share of 36% in 2023. Conversely, Asia Pacific region is anticipated to grow fastest CAGR of 14.40% in forecast period
  • Advances in rapid diagnostic technology led to development of more accurate, user-friendly, and cost-effective veterinary rapid test kits. Such advancements are expected to drive market growth

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Regional Scope
    • 1.1.2 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information/Data Analysis
    • 1.4.1 Information Analysis
  • 1.5 Market Formulation & Visualization
  • 1.6 Data Validation & Publishing
    • 1.6.1 Market Definitions
  • 1.7 Model Details
    • 1.7.1 Approach 1: Commodity Flow Analysis
      • 1.7.1.1 Hybrid Market Estimation Model
    • 1.7.2 Global Market: Cagr Calculation
    • 1.7.3 Approach 2: Parent Market Analysis
  • 1.8 List Of Secondary Sources

Chapter 2. Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot (Product, Technology, Animal Type)
  • 2.3 Segment Snapshot (Testing Category, End Use)
  • 2.4 Competitive Landscape Snapshot

Chapter 3. Veterinary Rapid Test Kit Market Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Analysis
  • 3.2 Veterinary Rapid Test Market Dynamics
    • 3.2.1 Market Driver Impact Analysis
      • 3.2.1.1 Increasing Demand For Point-Of-Care Testing
      • 3.2.1.2 Technological Advancements
      • 3.2.1.3 Increasing Incidence & Prevalence Of Diseases In Animals
      • 3.2.1.4 Increasing Animal Health Expenditure
    • 3.2.2 Market Restraint Impact Analysis
      • 3.2.2.1 Lack Of Awareness
      • 3.2.2.2 Limited Sensitivity And Specificity
    • 3.2.3 Market Opportunity Analysis
    • 3.2.4 Market Challenge Analysis
  • 3.3 Veterinary Rapid Test Market: Porter's 5 Forces Analysis
    • 3.3.1 Bargaining Power Of Buyers: Moderate
    • 3.3.2 Bargaining Power Of Suppliers: Low To Moderate
    • 3.3.3 Threat Of New Entrants: Low
    • 3.3.4 Threat Of Substitutes: Low
    • 3.3.5 Competitive Rivalry: High
  • 3.4 Veterinary Rapid Test Market: Pestel Analysis
    • 3.4.1 Political & Legal
    • 3.4.2 Economic
    • 3.4.3 Social
    • 3.4.4 Technological
    • 3.4.5 Environmental
  • 3.5 Pricing Analysis
  • 3.6 Regulatory Framework
    • 3.6.1 North America
    • 3.6.2 Europe
    • 3.6.3 Asia Pacific
    • 3.6.4 Latin America
    • 3.6.5 Middle East & Africa
  • 3.7 Technology Trend Analysis
  • 3.8 Covid-19 Impact Analysis

Chapter 4. Product Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 4.1 Veterinary Rapid Test Market By Product: Key Takeaways
  • 4.2 Product Movement Analysis & Market Share, 2023 & 2030
  • 4.3 Veterinary Rapid Test Market Estimates & Forecast, By Product (USD Million)
  • 4.4 Test Kits
    • 4.4.1 Test Kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.5 Reader
    • 4.5.1 Reader Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Testing Category Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 5.1 Veterinary Rapid Test Market By Testing Category: Key Takeaways
  • 5.2 Testing Category Movement Analysis & Market Share, 2023 & 2030
  • 5.3 Veterinary Rapid Test Market Estimates & Forecast, By Testing Category (USD Million)
  • 5.4 Virology
    • 5.4.1 Virology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5 Parasitology
    • 5.5.1 Parasitology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6 Bacteriology
    • 5.6.1 Bacteriology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.7 Clinical Chemistry
    • 5.7.1 Clinical Chemistry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.8 Others
    • 5.8.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Technology Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 6.1 Veterinary Rapid Test Market By Technology: Key Takeaways
  • 6.2 Technology Movement Analysis & Market Share, 2023 & 2030
  • 6.3 Veterinary Rapid Test Market Estimates & Forecast, By Technology (USD Million)
  • 6.4 Immunoassays
    • 6.4.1 Immunoassays Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5 PCR
    • 6.5.1 PCR Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Animal Type Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 7.1 Veterinary Rapid Test Market By Animal Type: Key Takeaways
  • 7.2 Animal Type Movement Analysis & Market Share, 2023 & 2030
  • 7.3 Veterinary Rapid Test Market Estimates & Forecast, By Animal Type (USD Million)
    • 7.3.1 Veterinary Rapid Test Market Estimates & Forecast, By Companion Animals (USD Million)
    • 7.3.2 Veterinary Rapid Test Market Estimates & Forecast, By Production Animal (USD Million)
  • 7.4 Companion Animals
    • 7.4.1 Companion Animals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2 Dogs
      • 7.4.2.1 Dogs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3 Cats
      • 7.4.3.1 Cats Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4 Horses
      • 7.4.4.1 Horses Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5 Others
      • 7.4.5.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5 Production Animal
    • 7.5.1 Production Animal Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2 Cattle
      • 7.5.2.1 Cattle Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3 Poultry
      • 7.5.3.1 Poultry Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4 Swine
      • 7.5.4.1 Swine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5 Others
      • 7.5.5.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. End-Use Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 8.1 Veterinary Rapid Test Market By End Use: Key Takeaways
  • 8.2 End-Use Movement Analysis & Market Share, 2023 & 2030
  • 8.3 Veterinary Rapid Test Market Estimates & Forecast, By End Use (USD Million)
  • 8.4 Veterinary Hospitals & Clinics
    • 8.4.1 Veterinary Hospital/Clinic Laboratories Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5 Homecare Settings
    • 8.5.1 Homecare Settings Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6 Others
    • 8.6.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Regional Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 9.1 Regional Outlook
  • 9.2 Regional Market Share Analysis, 2023 & 2030
  • 9.3 Regional Marketplace, Key Takeaways
  • 9.4 Regional Marketplace, Key Takeaways
  • 9.5 Regional Marketplace, Key Takeaways
  • 9.6 North America
    • 9.6.1 North America Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2 U.S.
      • 9.6.2.1 Key Country Dynamics
      • 9.6.2.2 U.S. Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3 Canada
      • 9.6.3.1 Key Country Dynamics
      • 9.6.3.2 Canada Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7 Europe
    • 9.7.1 Europe Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.2 Germany
      • 9.7.2.1 Key Country Dynamics
      • 9.7.2.2 Germany Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.3 Uk
      • 9.7.3.1 Key Country Dynamics
      • 9.7.3.2 Uk Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.4 France
      • 9.7.4.1 Key Country Dynamics
      • 9.7.4.2 France Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.5 Spain
      • 9.7.5.1 Key Country Dynamics
      • 9.7.5.2 Spain Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.6 Italy
      • 9.7.6.1 Key Country Dynamics
      • 9.7.6.2 Italy Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.7 Sweden
      • 9.7.7.1 Key Country Dynamics
      • 9.7.7.2 Sweden Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.8 Denmark
      • 9.7.8.1 Key Country Dynamics
      • 9.7.8.2 Denmark Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.9 Norway
      • 9.7.9.1 Key Country Dynamics
      • 9.7.9.2 Norway Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8 Asia Pacific
    • 9.8.1 Asia Pacific Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.2 Japan
      • 9.8.2.1 Key Country Dynamics
      • 9.8.2.2 Japan Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.3 China
      • 9.8.3.1 Key Country Dynamics
      • 9.8.3.2 China Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.4 India
      • 9.8.4.1 Key Country Dynamics
      • 9.8.4.2 India Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.5 Australia
      • 9.8.5.1 Key Country Dynamics
      • 9.8.5.2 Australia Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.6 South Korea
      • 9.8.6.1 Key Country Dynamics
      • 9.8.6.2 South Korea Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.9 Latin America
    • 9.9.1 Latin America Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.9.2 Brazil
      • 9.9.2.1 Key Country Dynamics
      • 9.9.2.2 Brazil Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.9.3 Mexico
      • 9.9.3.1 Key Country Dynamics
      • 9.9.3.2 Mexico Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.9.4 Argentina
      • 9.9.4.1 Key Country Dynamics
      • 9.9.4.2 Argentina Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.10 Mea
    • 9.10.1 Mea Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.10.2 South Africa
      • 9.10.2.1 Key Country Dynamics
      • 9.10.2.2 South Africa Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.10.3 Saudi Arabia
      • 9.10.3.1 Key Country Dynamics
      • 9.10.3.2 Saudi Arabia, Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.10.4 Uae
      • 9.10.4.1 Key Country Dynamics
      • 9.10.4.2 Uae Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.10.5 Kuwait
      • 9.10.5.1 Key Country Dynamics
      • 9.10.5.2 Kuwait Veterinary Rapid Test Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10 Competitive Landscape

  • 10.1 Market Participant Categorization
  • 10.2 Participants Overview
  • 10.3 Financial Performance
  • 10.4 Product Benchmarking
  • 10.5 Market Position Analysis, 2023 (Heat Map Analysis)
  • 10.6 Strategy Mapping
    • 10.6.1 Mergers And Acquisitions
    • 10.6.2 Launch
    • 10.6.3 Partnerships & Collaborations
    • 10.6.4 Expansion
    • 10.6.5 Others
  • 10.7 List of Other Key Market Players
  • 10.8 Company Profiles
    • 10.8.1. Zoetis.
      • 10.8.1.1. Participant's overview
      • 10.8.1.2. Financial performance
      • 10.8.1.3. Product benchmarking
      • 10.8.1.4. Strategic initiatives
    • 10.8.2. IDEXX Laboratories, Inc.
      • 10.8.2.1. Participant's overview
      • 10.8.2.2. Financial performance
      • 10.8.2.3. Product benchmarking
      • 10.8.2.4. Strategic initiatives
    • 10.8.3. Virbac.
      • 10.8.3.1. Participant's overview
      • 10.8.3.2. Financial performance
      • 10.8.3.3. Product benchmarking
      • 10.8.3.4. Strategic initiatives
    • 10.8.4. Heska Corporation (Mars Inc.)
      • 10.8.4.1. Participant's overview
      • 10.8.4.2. Financial performance
      • 10.8.4.3. Product benchmarking
      • 10.8.4.4. Strategic initiatives
    • 10.8.5. Thermo Fisher Scientific, Inc.
      • 10.8.5.1. Participant's overview
      • 10.8.5.2. Financial performance
      • 10.8.5.3. Product benchmarking
      • 10.8.5.4. Strategic initiatives
    • 10.8.6. Neogen Corporation.
      • 10.8.6.1. Participant's overview
      • 10.8.6.2. Financial performance
      • 10.8.6.3. Product benchmarking
      • 10.8.6.4. Strategic initiatives
    • 10.8.7. Prometheus Bio Inc.
      • 10.8.7.1. Participant's overview
      • 10.8.7.2. Financial performance
      • 10.8.7.3. Product benchmarking
      • 10.8.7.4. Strategic initiatives
    • 10.8.8. Fassisi GmbH.
      • 10.8.8.1. Participant's overview
      • 10.8.8.2. Financial performance
      • 10.8.3.3. Product benchmarking
      • 10.8.8.4. Strategic initiatives
    • 10.8.9. Biopanda Reagents Ltd.
      • 10.8.9.1. Participant's overview
      • 10.8.9.2. Financial performance
      • 10.8.9.3. Product benchmarking
      • 10.8.9.4. Strategic initiatives
    • 10.8.10. Boster Biological Technology.
      • 10.8.10.1. Participant's overview
      • 10.8.10.2. Financial performance
      • 10.8.10.3. Product benchmarking
      • 10.8.10.4. Strategic initiatives

Chapter 11 Key Takeaways

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦